These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25058)

  • 1. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental studies of the specificity and aspecificity of a beta-adrenolytic agent, bunitrolol (Kö 1366)].
    Marmo E; Lampa E; Rossi F; Caputi AP; Chieppa S; Vacca C; Giordano L; Pedone P
    Arch Sci Med (Torino); 1978; 135(1):15-56. PubMed ID: 25057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid)].
    Marmo E; Ungaro B; Giordano L
    Minerva Cardioangiol; 1971 Feb; 19(2):86-115. PubMed ID: 4396734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of compound IZ35 on the beta-adrenergic mediator system].
    Markov M; Zheliazkov D; Ivanov Ch
    Eksp Med Morfol; 1990; 29(4):33-9. PubMed ID: 1965891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
    Tanenaka T; Tachikawa S
    Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
    Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Combined effects of Lb46 resp. practolol and histamine on parameters of respiration and circulation in guinea pigs.
    Kilian U; Dittmann EC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R47. PubMed ID: 4152364
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological considerations on cetiedil, a drug with prevalent hemodynamic activity].
    Marmo E; Caputi A; Rossi F; Lampa E; Giordano L; Vacca C; Alise G; Somma A; Imperatore A
    Clin Ter; 1979 Jul; 90(1):11-45. PubMed ID: 535327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
    Hamada Y; Sato I; Ito K; Kuwabara S; Kojima Y
    Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on the pharmacology of a beta-adrenolytic agent: H 56-28 alprenolol. Studies with a special regard to the cardiovascular system, tracheal, gastric, intestinal, splenic and deferent muscles].
    Marmo E
    Clin Ter; 1971 Jan; 56(2):121-76. PubMed ID: 4397371
    [No Abstract]   [Full Text] [Related]  

  • 17. Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat.
    Levy B
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):143-6. PubMed ID: 4147749
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.